Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BS.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.272NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.371NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.353NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.407NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.12.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.22 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.128NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.296NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.412NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.421NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.364NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.82NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.251NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.469NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used